Bernard Poiesz MD in Auburn, New York

Medical School: Perelman School Of Med At The University Of Pennsylvania
Graduation Year: 1974
The Primary Medical Specialty for Bernard Poiesz MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 50
PAC (PECOS ID)#: 6305758632
NPI #: 1962431767
NPI Created On: 07/02/2006
NPI Last Updated Listed as: 10/20/2010
Primary Taxonomy Code: 207RH0003X
License Number:
129823
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
2. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
3. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
4. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
5. Infusion of chemotherapy into a vein up to 1 hour
6. Infusion of chemotherapy into a vein
7. New patient office or other outpatient visit, typically 60 minutes
8. Established patient office or other outpatient visit, typically 10 minutes
9. Established patient office or other outpatient visit, typically 15 minutes
10. Established patient office or other outpatient visit, typically 15 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Initial hospital inpatient care, typically 70 minutes per day
14. Subsequent hospital inpatient care, typically 25 minutes per day
15. Subsequent hospital inpatient care, typically 35 minutes per day
16. Hospital discharge day management, more than 30 minutes
17. Physician telephone patient service, 21-30 minutes of medical discussion
18. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
19. Injection, omalizumab, 5 mg
20. Injection, methylprednisolone sodium succinate, up to 125 mg